Conference presentations

Welcome and introduction
Professor Anna Maria Geretti, University of Liverpool

What does success look like?
Chair: Professor Paul Griffiths, University College London

Global rinderpest eradication: a triumph for animal health, a great benefit to human health
Dr Michael Baron, The Pirbright Institute

Is eradication of poliomyelitis in sight?
Professor David Salisbury, Chair, WHO Global Commission for the Certification of Poliomyelitis Eradication

Q&A

Keynote lecture Offered in association with The BMJ STI Journal and BASHH
Chair: Dr Olwen Williams, Betsi Cadwaladr University Health Board, Wales

Will vaccination eliminate HPV disease?
Dr Richard Gilson, University College London

Q&A

HIV: a paradigm of disease control?
Chair: Professor Margaret Johnson, Royal Free London NHS Foundation Trust

Clinical Case 1
Dr Rachel Herbert, North Middlesex University Hospital

Have we won the clinical battle against HIV drug resistance?
Moderator: Professor Anna Maria Geretti

The case for
Dr Ana Milinkovic, Chelsea and Westminster Hospital, London

The case against
Dr Tristan Barber, Royal Free London NHS Foundation Trust

The myth or reality of an HIV cure: give us hope!
Professor Sarah Fidler, Imperial College Healthcare NHS Trust, London

Panel debate: What does the future hold for HIV?
Dr Tristan Barber, Royal Free London NHS Foundation Trust
Dr Ana Milinkovic, Chelsea and Westminster Hospital, London
Mr Simon Collins, HIV i–Base
Professor Sarah Fidler, Imperial College Healthcare NHS Trust, London
Professor Anna Maria Geretti, University of Liverpool
Dr Olwen Williams, Betsi Cadwaladr University Health Board, Wales

Focus on hepatitis C
Chair: Mrs Fiona Marra, University of Liverpool

Clinical Case 2
Dr Brendan Healy, University Hospital of Wales, Cardiff

Latest guidance on hepatitis C drug resistance
Dr Daniel Bradshaw, Public Health England

Is elimination of hepatitis C in sight for the UK?
Professor Graham Foster, Queen Mary’s, University of London and Barts Health NHS Trust

Panel debate: Hepatitis C in the UK: successes, challenges, and opportunities
Dr Sanjay Bhagani, Royal Free London NHS Foundation Trust
Dr Daniel Bradshaw, Public Health England
Professor Graham Foster, Queen Mary’s, University of London and Barts Health NHS Trust
Dr Brendan Healy, University Hospital of Wales, Cardiff
Mrs Fiona Marra, University of Liverpool
Dr Emma Thomson, University of Glasgow Centre for Virus Research

Lunch and networking

Focus on hepatitis B Offered in association with BASL / BVHG
Chair: Dr Shevanthi Nayagam, Imperial College London

Theoretical opportunities and practical limitations of seeking to eradicate hepatitis B
Dr Patrick Kennedy, Queen Mary’s, University of London and Barts Health NHS Trust

Novel hepatitis B biomarkers for profiling and guiding management
Professor Florian van Boemmel, University of Leipzig, Germany

Panel debate: What stands in the way of eliminating hepatitis B?
Professor Florian van Boemmel, University of Leipzig, Germany
Dr Patrick Kennedy, Queen Mary’s, University of London and Barts Health NHS Trust
Dr Shevanthi Nayagam, Imperial College London
Dr Ivana Carey, King’s College Hospital, London

Focus on hepatitis B continued
Chair: Dr Shevanthi Nayagam, Imperial College London

Clinical Case 3
Dr Giovanni Villa, Brighton and Sussex Medical School

Forgotten, not gone: Hepatitis Delta in the world
Dr Alexander Stockdale, University of Liverpool on behalf of the Delta Study Group

Q&A

The future
Chair: Professor David Salisbury, Chair, WHO Global Commission for the Certification of Poliomyelitis Eradication

The next candidate for eradication: Is measles on your list?
Dr Kevin Brown, Public Health England

An emerging threat or sporadic events? Monkey pox
Dr Paul Hine, Royal Liverpool University Hospital

Q&A

Summary and close
Professor Paul Griffiths, University College London